You have 9 free searches left this month | to do more

semaglutide

Semaglutide is a drug used to treat Diabetes Mellitus, Type 2, Diabetes, Healthy, and other conditions. Semaglutide is being actively studied in 35 studies and prior, has been studied in 93.

Top SponsorsTop SitesTop Investigators
Novo Nordisk A/SNovo Nordisk Investigational SiteAndrej Janez
Eli Lilly and CompanyValley Clinical Trials, Inc.Flemming Dela
AstraZenecaAKH - Medical University of ViennaHiddo Lambers Heerspink
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Not yet recruiting
  • Atheroscleroses, Coronary
  • Semaglutide
  • (no location specified)
2021-09-27
Sep 27, 2021
N
Completed
  • Healthy Volunteers
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Mainz, Germany
    Novo Nordisk Investigational Site
2021-06-23
Jun 23, 2021
N
Completed
  • Healthy Volunteers
  • +2 more
  • Semaglutide
  • Neuss, Germany
    Novo Nordisk Investigational Site
2021-05-20
May 20, 2021
R
Active, not recruiting
  • Type2 Diabetes
  • Malmö, Skane, Sweden
    Anders Rosengrentest
2021-09-21
Sep 21, 2021
N
N
Completed
  • Healthy Volunteers Type 2 Diabetes
  • Fukuoka, Japan
    Novo Nordisk Investigational Site
2021-09-13
Sep 13, 2021
U
Not yet recruiting
  • Type 2 Diabetes
  • +2 more
  • Semaglutide
  • Placebo
  • (no location specified)
2021-09-27
Sep 27, 2021
N
Completed
  • Overweight
  • Obesity
  • Semaglutide
  • Placebo
  • Berlin, Germany
    Novo Nordisk Investigational Site
2020-12-22
Dec 22, 2020
N
Completed
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Cambridge, Ontario, Canada
    Novo Nordisk Investigational Site
2021-08-31
Aug 31, 2021
N
Completed
  • Obesity
  • Overweight
  • Overland Park, Kansas
    Novo Nordisk Investigational Site
2021-05-04
May 4, 2021
N
Completed
  • Diabetes Mellitus, Type 2
  • Neuss, Germany
    Novo Nordisk Investigational Site
2021-09-28
Sep 28, 2021
N
Recruiting
  • Non-Alcoholic Steatohepatitis
  • Non-Alcoholic Fatty Liver Disease
  • Semaglutide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-07
Sep 7, 2021
N
Completed
  • Hepatobiliary Disorders
  • Non-alcoholic Fatty Liver Disease
  • Semaglutide
  • Placebo
  • Mainz, Germany
  • +1 more
2021-03-02
Mar 2, 2021
N
Recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Placebo (semaglutide)
  • Graz, Austria
  • +3 more
2021-06-16
Jun 16, 2021
N
Completed
  • Metabolism and Nutrition Disorders
  • Overweight or Obesity
  • Tempe, Arizona
  • +1 more
2021-07-01
Jul 1, 2021
T
Recruiting
  • Diabetes type2
  • Semaglutide
  • label recommended titration
  • Tel Aviv, Israel
    Tel-Aviv Medical Center
2020-06-24
Jun 24, 2020
T
Recruiting
  • Type 2 Diabetes
  • Semaglutide
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic
2021-01-25
Jan 25, 2021
U
Not yet recruiting
  • Obesity
  • Albuminuria
  • Semaglutide
  • Placebo
  • Calgary, Alberta, Canada
  • +12 more
2021-05-11
May 11, 2021
L
Completed
  • Type 2 Diabetes
  • Semaglutide
  • Toronto, Ontario, Canada
    LMC Diabetes & Endocrinology
2020-02-19
Feb 19, 2020
N
Completed
  • Diabetes
  • Healthy
  • semaglutide
  • +3 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
2020-02-13
Feb 13, 2020
N
Completed
  • Diabetes
  • Healthy
  • semaglutide
  • +3 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
2020-02-13
Feb 13, 2020